Laser Photonics Approves Immediate Exercise of Series A-5 and A-6 Warrants
LASE•At its June 26 meeting, Laser Photonics shareholders representing 37.1% of 38.6 million outstanding shares approved inducement agreements for Series A-5 and A-6 warrants. The approvals satisfy Nasdaq rules and enable immediate exercise of the March 15 and April 26, 2026 warrants.
1. Special Meeting Results
On June 26, 2026, Laser Photonics held a special meeting with a record date of May 13, 2026. Of 38,568,263 shares outstanding, 14,300,930 shares (37.08%) were voted in person or by proxy. Proposal approvals recorded votes of 14,183,036 for and 106,775 against for the March 15 agreement, and 14,146,320 for and 143,491 against for the April 26 agreement.
2. Warrant Exercise Terms
The approved warrant inducement agreements dated March 15 and April 26, 2026 permit exercise of the Series A-5 and A-6 common stock purchase warrants. With shareholder approval obtained, the warrants are now exercisable under their original terms, subject to the specified exercise period and pricing.
3. Potential Financial Impact
Immediate exercisability may lead to new capital inflows when warrant holders convert, but also increases share count upon exercise. Investors should assess potential dilution based on outstanding warrant volume and exercise prices to evaluate effects on share value and earnings per share.
